skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent Kit)
Assay, Glycosylated Hemoglobin. 510(k) K173127, from Skyla Corporation H.S.P.B (Hsinchu City, TW). Product code LCP, class 2.
As of Nov 20, 2026, K173127 is an FDA 510(k) held by Skyla Corporation H.S.P.B, substantially equivalent on Sep 25, 2018 after 361 days, with no recalls tied to it in FDA's recall database.
- Review time: 361 days
- Recalls: 0
The skyla Hi Hemoglobin A1c System, consisting of the skyla Hi Analyzer and skyla Hi Hemoglobin A1c Reagent Kit is an in-vitro diagnostic test for quantitative measurement of the percent concentration (%) of glycated hemoglobin (HbA1c %) in venous and finger-stick capillary whole blood.
- Alere Afinion HbA1c, Alere Afinion AS100 AnalyzerK151809 · Alere Technologies AS · Sep 25, 2015
- Q-Pad Test SystemK231465 · Qurasense · Dec 6, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 29, 2017
- Review panel
- Hematology
- Regulation
- 21 CFR 864.7470
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files